Events 07/03/23-07/31/23 Practical Research Project for Rare/Intractable Diseases Fiscal 2022 Outcomes Conference

Event Information

The Japan Agency for Medical Research and Development (AMED) is set to host in online format the Fiscal 2022 Outcomes Conference titled "Bringing light to rare diseases with the power of medicine and research." (participation is free of charge).
Continuous efforts are under way in Japan to address and cure rare and intractable diseases. This conference will present reports on the progress and outcomes of the latest research and development aiming for novel treatments and diagnoses.
We look forward to welcoming many participants including researchers, patients and their families, and company representatives.

Please click above image to open the Forum Poster PDF

Event outline

Name

Practical Research Project for Rare/Intractable Diseases Fiscal 2022 Outcomes Conference “Bringing light to rare diseases with the power of medicine and research.”

Date & Time

07/03/23 Mon 10:00-07/31/23 Mon 23:59

(Live event) Monday, July 3, 2023

Venue

Online event

Target

Researchers, Patients and their families, and Company representatives

Fee

Free

How to Apply

<https://amed2022nambyo.com/2022/teaser/>
Please register from the dedicated participation registration form.

Organizer

Japan Agency for Medical Research and Development(AMED)

Program(Live event, July 3)

時間 内容
1:00p.m.-1:05p.m Opening Remarks
1:05p.m.-1:15p.m Program overview
1:15p.m.-1:45p.m

Session 1
Dr. TANIGUCHI Masahiko(Hospital Director, St. Mary's Hospital)
Presentation Title:「Creation of evidence on Okinawa-type neurogenic muscular atrophy by utilizing the patient registry」

Dr. INOUE Haruhisa(Professor, Center for iPS Cell Research and Application, Kyoto University)
Presentation Title:「HMSN-P Registry Study toward Trial-Ready Cohort Construction」

1:45p.m.-2:15p.m

Session 2
Dr. OGI Tomoo(Professor, Department of Genetics, Research Institute of Environmental Medicine, Nagoya University)
Presentation Title:「Understanding of the pathogenesis of rare intractable diseases caused by genome instability」

2:15p.m.-2:45p.m

Session 3
Dr. KAJI Ryuji(Designated Professor, Department of Neurodegenerative Disorders Research, Graduate School of Biomedical Sciences, Tokushima University)
Presentation Title:「Clinical development of ultra-high dose methylcobalamin in ALS」

2:45p.m.-2:55p.m Break
2:55p.m.-3:25p.m

Session 4
Dr. YOKOTA Takanori(Professor, Department of Neurology and Neurological Science, Tokyo Medical and Dental University)
Presentation Title:「Developing antisense oligonucleotide therapy against spinocerebellar ataxia type31」

3:25p.m.-3:55p.m Session 5
Dr. FUJIU Katsuhito(Project Associate Professor, Department of Advanced Cardiology, Graduate School of Medicine, The University of Tokyo)
Presentation Title:「Basic research and clinical applications to prevent cardiac death」
3:55p.m.-4:25p.m

Session 6
Dr. MIZOGUCHI Akira(Department of Personalized Cancer Immunotherapy, Graduate School of Medicine, Mie University)
Presentation Title:「Development of a novel cellular imaging technology realizing more accurate surgical operations on the Hirschsprung disease, a rare intractable infantile disease ----- A technology supporting real-time pathological diagnosis using curcumin vital staining and multiphoton laser scanning endomicroscopy -----」

4:25p.m.-4:27p.m

Closing Remarks

*Program contents and other information are subject to change.
*All lectures and discussions at the event will be held in Japanese.

Contact

About the conference

Contact to administrative office (Planning office SMS)
E-Mail: nambyo2022”AT"plan-sms.co.jp

About the program

Japan Agency for Medical Research and Development
Division of Strategic Planning and Evaluation, Department of Innovative Drug Discovery and Development
Practical Research Project for Rare / Intractable Diseases
E-mail:nambyo-r”AT"amed.go.jp
※change “AT”to @ before sending

Last updated 06/16/23